Wednesday's hottest premarket stocks 🔥

The market turned in a weak performance in its first day back from the long weekend. Large-cap indexes edged lower, and the small-cap Russ 2K sold off.

S&P 500 and Dow futures are both down 0.3% in early premarket trading.

Regime Change At Federal Reserve?

The Fed just began the rollout of a new technology that'll "shake the US financial system".

It'll likely go down in history as the biggest change to the financial system since Western Union’s "lightning lines."

Take These 3 Steps Now to Maximize This Opportunity

📉 Chinese Stocks Touch News Lows
Chinese markets experienced significant sell-offs on Wednesday, triggered by a series of discouraging economic reports.

The data painted a grim picture of the country's current economic state, leading to widespread selling of Chinese stocks.

The benchmark CSI 300 index fell 2.2%, reaching a near five-year low.

Hong Kong's Hang Seng Index suffered a 3.7% drop, its lowest close in about 15 months. This marks a substantial loss since its peak in February 2021.

🔍 Economic Challenges
China’s economy grew by 5.2% last year, marginally surpassing the government's targets.

However, this silver lining is overshadowed by multiple economic hurdles.
The country is grappling with various challenges, such as deflation, weakening export demand, and a prolonged downturn in the real estate sector.

This overall market response reflects investor concerns about China's economic health and future prospects, amidst internal and external economic pressures.

BullFrog AI [BFRG] - Last Close: $2.64

In an early morning press release, the AI company said its collaboration with the Lieber Institute for Brain Development may have produced a breakthrough.

BullFrog said early findings from the partnership have successfully stratified brain expression data, which could provide insights into psychiatric conditions.

The study clustered subjects based solely on their biological data, independent of their behavioral diagnoses.

The approach highlights differences and similarities in biological pathways across various brain disorders.

BFRG is up 23.1% on more than 3 million shares traded.

My Take: BFRG is coming off a pullback, but this catalyst could help it regain its form.

ZyVersa Therapeutics [ZVSA] - Last Close: $0.6925

This tiny biotech is getting a boost after publishing an article in the peer-reviewed publication Acta Neuropathologica Communications.

The company said the article demonstrates “inflammasome activation enhances cancer metastasis to the brain in women with TNBC.”

ZVSA is up 80.5% on the news, with more than 3.5 million shares changing hands in the premarket.

My Take: ZVSA has struggled as of late, but this rally could put it back on track. Shares could find support at the $1 mark.

INVO Bioscience [INVO] - Last Close: $1.05

This tiny biotech filed new disclosures in the lead up to its proposed merger with NAYA Biosciences early this morning.

INVO Bio will hold a shareholder vote to approve the merger soon, and it’s also facilitating a public offering.

After Tuesday’s close, the company published a Form S-4 filing detailing its plans for the offering and the agenda for the upcoming shareholder meeting.
INVO is up 16.5% in the premarket on thin trading volume.

My Take: INVO’s modest mover higher doesn’t have a lot of volume to support it. I think this rally could materialize quickly once its momentum begins to fade.

Airspan Networks [MIMO] - Last Close: $0.0769

This morning, this IT firm announced a new partnership with GCT Semiconductor to develop a “state-of-the-art” RF module.

Airspan said the RF module will be designed for use in various devices, and the company is building out a scalable virtual core network to support the systems.

It also announced the launch of a new family of vRAN radios covering the sub 1Ghz spectrum.

MIMO is today’s top premarket stock with a 242.0% gain on 38 million shares traded.

My Take: MIMO has an extremely small float, so this stock could experience significant volatility in today’s session.